Zobrazeno 1 - 10
of 99
pro vyhledávání: '"C, Esche"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michael P. Lux, P. A. Fasching, R. L. Schild, C. Esche, Grit Mehlhorn, Tamme W. Goecke, M. W. Beckmann, Helge Binder
Publikováno v:
Geburtshilfe und Frauenheilkunde. 66
Afterpains are occurring in approx. 30-40% of all multiparous women. A pilot study testing the efficacy of TENS vs. metamizole proved TENS to be effective. 118 of 541 multiparous women were randomly assigned to one of 4 groups. Group 1: TENS vs. meta
Publikováno v:
Zeitschrift für Geburtshilfe und Neonatologie. 209
Autor:
C, Esche, G V, Shurin, J M, Kirkwood, G Q, Wang, H, Rabinowich, G, Pirtskhalaishvili, M R, Shurin
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7
Melanoma escapes host defenses through a variety of means, including the elimination of immune effector cells within the tumor microenvironment. We have reported recently that murine and human tumors including melanoma induce premature apoptosis of d
Publikováno v:
Current opinion in molecular therapeutics. 1(1)
Dendritic cells (DC) are the most potent antigen presenting cells (APC) and the only ones capable of presenting novel antigens to naïve T-cells. Large numbers of DC can be generated in vitro in the presence of appropriate cytokine cocktails using ei
Publikováno v:
European journal of immunology. 30(9)
Interleukin-12 (IL-12) and Flt3 ligand (FL) regulate hematopoiesis by stimulating proliferation, differentiation and migration of progenitor and/or stem cells. In this study, we evaluated the in vivo effect of IL-12 alone or in combination with FL on
Publikováno v:
Forum (Genoa, Italy). 10(3)
Incidence and mortality of human malignant melanoma has risen rapidly over recent decades. Systemic therapies for metastatic cutaneous melanoma, the most aggressive of all skin cancers, remain disappointing although immunological treatment has been m
Autor:
M T, Lotze, M, Shurin, C, Esche, H, Tahara, W, Storkus, J M, Kirkwood, T L, Whiteside, E M, Elder, H, Okada, P, Robbins
Publikováno v:
The cancer journal from Scientific American. 6
Recombinant interleukin (IL)-2 administration can mediate regression of solid tumors in patients with melanoma and renal cell carcinoma. A better understanding of the mechanisms of IL-2-mediated antitumor effects has led to the investigation of novel
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 163(6)
The cytokine FLT3 ligand (FL) enhances dendritic cell (DC) generation and has therefore been proposed as a means to boost antitumor immunity. Vascular endothelial growth factor (VEGF) is produced by a large percentage of tumors and is required for de
Autor:
C, Esche, A, Gambotto, Y, Satoh, V, Gerein, P D, Robbins, S C, Watkins, M T, Lotze, M R, Shurin
Publikováno v:
European journal of immunology. 29(7)
We have recently demonstrated that murine and human tumors induce apoptosis of dendritic cells (DC). Here, we evaluated the effect of CD40 ligation on the survival of tumor-associated DC and tumor growth. Retroviral transduction of MC38 colon carcino